CTLA4 and osteomyelitis: They demonstrated that luteolin, chryseriol, kaempferol, and quercetin are the main active compounds of WWXDD, which are capable for downregulating the percentage of Treg cells via IL-2/STAT5 and suppressing the increased level of Foxp3 and CTLA-4 in osteomyelitis (113).